QGEN Qiagen NV

  1. Stocks
  2. Healthcare
  3. NYSE: QGEN

Price (delayed)

$44.07

Market cap

$9.11B

P/E Ratio

22.83

Dividend/share

$2.64

EPS

$1.93

Enterprise value

$9.99B

?
Relative Growth: Rel. Growth: 48
Relative Strength: Rel. Strength: 44
Relative Valuation: Rel. Valuation: 53
Relative Profitability: Rel. Profitability: 76

QIAGEN N.V., (QIAGEN) is a holding company, which provides sample and assay technologies. The consumable products such as sample and assay kits and automated instrumentation systems provides customers to transform ...

Highlights
Qiagen's EPS has increased by 14% YoY and by 3.2% from the previous quarter
The company's net income rose by 10% YoY
Qiagen's quick ratio has surged by 71% YoY but it has decreased by 6% QoQ
The price to earnings (P/E) is 47% lower than the 5-year quarterly average of 43.4 but 2.8% higher than the last 4 quarters average of 22.2
The debt has grown by 14% year-on-year
QGEN's equity is down by 4.2% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.qiagen.com
Peers: TMO BDX GE TECH

Key stats

What are the main financial stats of QGEN

QGEN stock price

How has the Qiagen stock price performed over time
Intraday
-1.85%
1 week
2.61%
1 month
8.73%
1 year
-10.3%
YTD
-2%
QTD
12.71%

Financial performance

How have Qiagen's revenue and profit performed over time
Revenue
$2.1B
Gross profit
$1.31B
Operating income
$445.43M
Net income
$409.32M
Gross margin
62.2%
Net margin
19.5%
The company's net income rose by 10% YoY
The operating margin has declined by 8% year-on-year but it rose by 2.4% since the previous quarter
The net margin has grown by 7% year-on-year
Qiagen's operating income has decreased by 4.9% YoY but it has increased by 2.4% QoQ

Price vs fundamentals

How does QGEN's price correlate with its fundamentals

Growth

What is Qiagen's growth rate over time

Valuation

What is Qiagen stock price valuation
QGEN P/E details
P/E
22.83
P/B
2.71
P/S
4.33
EV/EBIT
19.93
EV/EBITDA
14.2
EV/Sales
4.76
The price to earnings (P/E) is 47% lower than the 5-year quarterly average of 43.4 but 2.8% higher than the last 4 quarters average of 22.2
Qiagen's EPS has increased by 14% YoY and by 3.2% from the previous quarter
The stock's price to book (P/B) is 10% less than its 5-year quarterly average of 3.0 but 4.2% more than its last 4 quarters average of 2.6
QGEN's equity is down by 4.2% YoY
QGEN's price to sales (P/S) is 12% lower than its 5-year quarterly average of 4.9
The company's revenue rose by 3% YoY

Efficiency

How efficient is Qiagen business performance
The company's return on invested capital fell by 18% YoY and by 3.2% QoQ
QGEN's ROE is up by 8% YoY and by 2.7% from the previous quarter
Qiagen's ROS has decreased by 7% YoY
QGEN's return on assets is up by 4.7% year-on-year

Dividends

What is QGEN's dividend history
Dividend details
DPS
$2.64
Dividend yield
5.99%
Payout ratio
136.8%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Qiagen financials performed over time
Qiagen's total assets is 133% higher than its total liabilities
The current ratio has soared by 77% YoY but it is down by 11% from the previous quarter
Qiagen's quick ratio has surged by 71% YoY but it has decreased by 6% QoQ
The debt is 51% smaller than the equity
Qiagen's debt to equity has increased by 20% YoY
The debt has grown by 14% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.